David Xavier Thomas

David Xavier Thomas, PhD, is currently a Project Leader at Boston Consulting Group (BCG), where they lead engagements in pharma, healthcare, and national health policy. David is also completing an MSc in Health Data Science at University College London through a competitive sponsorship from BCG. Previously, they held research roles at Imperial College London, focusing on Alzheimer’s disease, and at Harvard University, where they organized international collaborations on neurotoxicity. David earned a PhD in Neuroscience at UCL and a BSc in Biochemistry from the University of Bristol, graduating with first-class honors.